Biopharmaceutical company ATAI Life Sciences plans to make an initial investment of 5 million dollars to purchase Bitcoin

2025-03-21 08:46:06

Collection

ChainCatcher news, according to CoinDesk, the biopharmaceutical public company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy, planning to initially invest $5 million to purchase Bitcoin. Following this news, ATAI's stock price briefly rose.

The company's chairman, Christian Angermayer, stated that the company plans to initially invest $5 million to purchase Bitcoin while retaining sufficient cash, short-term securities, and public equity to ensure the company's operating funds until 2027.

(Source Link)

ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click "Report", and we will handle it promptly.